Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 422,900 shares, an increase of 14.5% from the September 15th total of 369,200 shares. Approximately 5.8% of the shares of the company are […]